Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $35.51 USD
Change Today +0.29 / 0.82%
Volume 129.4K
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

phibro animal health corp-a (PAHC) Snapshot

Open
$35.57
Previous Close
$35.22
Day High
$35.80
Day Low
$34.61
52 Week High
07/1/15 - $40.54
52 Week Low
09/3/14 - $18.58
Market Cap
1.4B
Average Volume 10 Days
139.5K
EPS TTM
$1.42
Shares Outstanding
17.5M
EX-Date
08/31/15
P/E TM
25.0x
Dividend
$0.40
Dividend Yield
1.13%
Current Stock Chart for PHIBRO ANIMAL HEALTH CORP-A (PAHC)

Related News

No related news articles were found.

phibro animal health corp-a (PAHC) Related Businessweek News

No Related Businessweek News Found

phibro animal health corp-a (PAHC) Details

Phibro Animal Health Corporation operates as a diversified developer, manufacturer, and marketer of a range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy, and aquaculture. It also sells specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment offers antibacterials, anticoccidials, and vaccines, which help prevent and manage infectious diseases in livestock and enhance food safety; and nutritional specialty products, which aid the continued health of livestock by enhancing nutrition to help improve health and performance. The Mineral Nutrition segment manufactures and markets approximately 450 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets various specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries, primarily in the United States. The company sells its animal health and mineral nutrition products through local sales offices either directly to integrated poultry, swine, and cattle integrators; or through commercial animal feed manufacturers, wholesalers, and distributors. It sells its performance products through local sales offices to the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation is headquartered in Teaneck, New Jersey.

1,100 Employees
Last Reported Date: 09/18/14

phibro animal health corp-a (PAHC) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $3.0M
Chief Operating Officer and Director
Total Annual Compensation: $914.7K
President of Animal Health
Total Annual Compensation: $708.5K
Compensation as of Fiscal Year 2014.

phibro animal health corp-a (PAHC) Key Developments

Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on September 23, 2015

The Board of Directors of Phibro Animal Health Corporation declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on September 23, 2015, to stockholders of record at the close of business on September 2, 2015.

Phibro Animal Health Corporation Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 04:15 PM

Phibro Animal Health Corporation Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 04:15 PM. Venue: Le Parker Meridien Hotel, 119 W. 56th Street, New York, NY 10019, United States. Speakers: Richard G. Johnson, Chief Financial Officer, Principal Accounting Officer and Member of Retirement Benefits Committee.

Phibro Animal Health Corporation Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015; Provides Earnings Guidance for the Year Ending June 30, 2015

Phibro Animal Health Corporation announced consolidated earnings results for the third quarter and nine months ended March 31, 2015. For the quarter, the company reported net sales of $187.5 million against $173.3 million a year ago. Operating income was $21.8 million against $17.3 million a year ago. Income before income taxes was $22.8 million against $8.3 million a year ago. Net income was $19.4 million against $6.4 million a year ago. Diluted net income per share was $0.49 against $0.21 a year ago. Adjusted EBITDA was $27.5 million against $22.4 million a year ago. EBITDA was $31.8 million against $22.2 million a year ago. Adjusted net income was $16.5 million against $14.0 million a year ago. Adjusted diluted net income per share was $0.41 against $0.36 a year ago. Adjusted operating income was $23.4 million against $18.5 million a year ago. Adjusted income before income taxes was $20.0 million against $15.1 million a year ago. Net cash provided by operating activities was $21.1 million against $0.2 million a year ago. Capital expenditures were $5.4 million against $4.5 million a year ago. For the year, the company reported net sales of $563.6 million against $508.2 million a year ago. Operating income was $66.7 million against $50.7 million a year ago. Income before income taxes was $63.0 million against $22.5 million a year ago. Net income was $55.3 million against $14.5 million a year ago. Diluted net income per share was $1.39 against $0.48 a year ago. Adjusted EBITDA was $83.0 million against $66.4 million a year ago. EBITDA was $89.5 million against $64.3 million a year ago. Adjusted net income was $50.9 million against $39.4 million a year ago. Adjusted diluted net income per share was $1.28 against $1.00 a year ago. Adjusted operating income was $70.4 million against $54.5 million a year ago. Adjusted income before provision for income taxes was $60.0 million against $44.3 million a year ago. Net cash provided by operating activities was $46.8 million against $16.6 million a year ago. Capital expenditures were $13.1 million against $14.2 million a year ago. For the year ending June 30, 2015, the company expects net sales will be approximately $749 to $754 million, an increase of 8% to 9%. This reflects a slowing of Animal Health rate of growth as some of Animal Health ex-U.S. customers have delayed or reduced purchases due to the strong U.S. dollar. The company expects Mineral Nutrition net sales for the balance of the year to be approximately even with last year, due to the overlap with strong net sales last year. Adjusted EBITDA will be approximately $109 to $110 million, an increase of 20% to 21%. Adjusted diluted EPS will be approximately $1.65 to $1.67 per share, compared with $1.22 last year. The company anticipates increased CapEx investment going forward for the remainder of current fiscal year and into next fiscal year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PAHC:US $35.51 USD +0.29

PAHC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €119.75 EUR +0.94
Novartis AG SFr.91.65 CHF 0.00
Virbac SA €199.60 EUR 0.00
Zoetis Inc $45.12 USD +1.14
View Industry Companies
 

Industry Analysis

PAHC

Industry Average

Valuation PAHC Industry Range
Price/Earnings 36.6x
Price/Sales 1.8x
Price/Book 59.5x
Price/Cash Flow 32.4x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHIBRO ANIMAL HEALTH CORP-A, please visit www.pahc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.